Most read articles by the same author(s)

• Sarah Blach, Christian Schaetti, Philip Bruggmann, Francesco Negro, Homie Razavi, Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland , Swiss Medical Weekly: Vol. 149 No. 1112 (2019)
• Urs Rusch, Sarah Robbins, Homie Razavi, Pietro Vernazza, Sarah Blach, Philip Bruggmann, Beat Müllhaupt, Francesco Negro, David Semela, Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions , Swiss Medical Weekly: Vol. 149 No. 0304 (2019)
• Philip Bruggmann, Sarah Blach, Pierre Deltenre, Jan Fehr, Roger D. Kouyos, Daniel Lavanchy, Beat Müllhaupt, Andri Rauch, Homie Razavi, Patrick Schmid, David Semela, Marcel Stöckle, Franco Negro, Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030 , Swiss Medical Weekly: Vol. 147 No. 4546 (2017)
• Philip Bruggmann, Francesco Negro, Florian Bihl, Sarah Blach, Daniel Lavanchy, Beat Müllhaupt, Homie Razavi, David Semela, Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland , Swiss Medical Weekly: Vol. 145 No. 4950 (2015)
• Philip Bruggmann, Bettina Maeschli, Hepatitis C micro-elimination among people on opioid agonist therapy is a low-hanging fruit , Swiss Medical Weekly: Vol. 150 No. 3738 (2020)